Syngene biologics facility to be operational for US, European customers from mid-year
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Sen spent a decade with Biocon and held various key roles,
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
More than 10,000 scientific publications containing EUDRAGIT
Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager
The drug will target specific genetic mutations prevalent in certain types of cancers
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
Subscribe To Our Newsletter & Stay Updated